| [1] |
Coates G, Clewes P, Lohan C, Stevenson H, Wood R, et al. 2023. Health economic impact of moderate-to-severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care data. |
| [2] |
Steinmetz JD, Culbreth GT, Haile LM, Rafferty Q, Lo J, et al. 2023. Global, regional, and national burden of osteoarthritis, 1990−2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. |
| [3] |
Wang Y, Li D, Lv Z, Feng B, Li T, et al. 2023. Efficacy and safety of Gutong Patch compared with NSAIDs for knee osteoarthritis: a real-world multicenter, prospective cohort study in China. |
| [4] |
Altman RD, Bedi A, Karlsson J, Sancheti P, Schemitsch E. 2016. Product differences in intra-articular hyaluronic acids for osteoarthritis of the knee. |
| [5] |
Zhu X, Chan YT, Yung PSH, Tuan RS, Jiang Y. 2020. Subchondral bone remodeling: a therapeutic target for osteoarthritis. |
| [6] |
Yuan C, Pan Z, Zhao K, Li J, Sheng Z, et al. 2020. Classification of four distinct osteoarthritis subtypes with a knee joint tissue transcriptome atlas. |
| [7] |
Stürmer T, Brenner H, Koenig W, Günther KP. 2004. Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. |
| [8] |
Christiansen BA, Anderson MJ, Lee CA, Williams JC, Yik JHN, et al. 2012. Musculoskeletal changes following non-invasive knee injury using a novel mouse model of post-traumatic osteoarthritis. |
| [9] |
Zhuo Q, Yang W, Chen J, Wang Y. 2012. Metabolic syndrome meets osteoarthritis. |
| [10] |
Khaledi F, Ghasemi S. 2022. A review on epigenetic effects of environmental factors causing and inhibiting cancer. |
| [11] |
Barter MJ, Bui C, Young DA. 2012. Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs. |
| [12] |
Espin-Garcia O, Baghel M, Brar N, Whittaker JL, Ali SA. 2022. Can genetics guide exercise prescriptions in osteoarthritis? |
| [13] |
Moore LD, Le T, Fan G. 2013. DNA methylation and its basic function. |
| [14] |
Zhu X, Chen F, Lu K, Wei A, Jiang Q, et al. 2019. PPARγ preservation via promoter demethylation alleviates osteoarthritis in mice. |
| [15] |
Hua B, Qiu J, Ye X, Kuang Y, Liu X. 2023. Epigenetic PPARγ preservation attenuates temporomandibular joint osteoarthritis. |
| [16] |
Stocum DL, Roberts WE. 2018. Part I: development and physiology of the temporomandibular joint. |
| [17] |
Chen X, Zhu X, Dong J, Chen F, Gao Q, et al. 2022. Reversal of epigenetic peroxisome proliferator-activated receptor-γ suppression by diacerein alleviates oxidative stress and osteoarthritis in mice. |
| [18] |
Wang C, Wang Y, Gu Y, Zhu Y, Yin R, et al. 2025. SPI1 facilitates microfracture-mediated cartilage regeneration in the elderly by enhancing bone marrow stromal cells ctemness. |
| [19] |
Shen J, Wang C, Li D, Xu T, Myers J, et al. 2017. DNA methyltransferase 3b regulates articular cartilage homeostasis by altering metabolism. |
| [20] |
Papageorgiou AA, Litsaki M, Mourmoura E, Papathanasiou I, Tsezou A. 2023. DNA methylation regulates Sirtuin 1 expression in osteoarthritic chondrocytes. |
| [21] |
Bradley EW, Carpio LR, McGee-Lawrence ME, Castillejo Becerra C, Amanatullah DF, et al. 2016. Phlpp1 facilitates post-traumatic osteoarthritis and is induced by inflammation and promoter demethylation in human osteoarthritis. |
| [22] |
Reid GD, Reid CG, Widmer N, Munk PL. 2010. Femoroacetabular impingement syndrome: an underrecognized cause of hip pain and premature osteoarthritis? |
| [23] |
Husen M, Leland DP, Melugin HP, Poudel K, Hevesi M, et al. 2023. Progression of osteoarthritis at long-term follow-up in patients treated for symptomatic femoroacetabular impingement with hip arthroscopy compared with nonsurgically treated patients. |
| [24] |
Kamenaga T, Shen J, Wu M, Brophy RH, Clohisy JC, et al. 2023. Epigenetic dysregulation of articular cartilage during progression of hip femoroacetabular impingement disease. |
| [25] |
Sarkar A, Liu NQ, Magallanes J, Tassey J, Lee S, et al. 2023. STAT3 promotes a youthful epigenetic state in articular chondrocytes. |
| [26] |
Iijima H, Gilmer G, Wang K, Bean AC, He Y, et al. 2023. Age-related matrix stiffening epigenetically regulates α-Klotho expression and compromises chondrocyte integrity. |
| [27] |
Zhang Y, He L, Yang Y, Cao J, Su Z, et al. 2023. Triclocarban triggers osteoarthritis via DNMT1-mediated epigenetic modification and suppression of COL2A in cartilage tissues. |
| [28] |
Shen J, Abu-Amer Y, O'Keefe RJ, McAlinden A. 2017. Inflammation and epigenetic regulation in osteoarthritis. |
| [29] |
Kawarai Y, Nakamura J, Hagiwara S, Suzuki-Narita M, Inage K, et al. 2024. Alterations in DNA methylation machinery in a rat model of osteoarthritis of the hip. |
| [30] |
Smeriglio P, Grandi FC, Davala S, Masarapu V, Indelli PF, et al. 2020. Inhibition of TET1 prevents the development of osteoarthritis and reveals the 5hmC landscape that orchestrates pathogenesis. |
| [31] |
Pandey A, Hoover M, Singla M, Bedi Y, Storaci H, et al. 2024. TET1 regulates skeletal stem–cell mediated cartilage regeneration. |
| [32] |
Kim S, Kaang BK. 2017. Epigenetic regulation and chromatin remodeling in learning and memory. |
| [33] |
Khan NM, Haqqi TM. 2018. Epigenetics in osteoarthritis: potential of HDAC inhibitors as therapeutics. |
| [34] |
Cai D, Yin S, Yang J, Jiang Q, Cao W. 2015. Histone deacetylase inhibition activates Nrf2 and protects against osteoarthritis. |
| [35] |
Ohzono H, Hu Y, Nagira K, Kanaya H, Okubo N, et al. 2023. Targeting FoxO transcription factors with HDAC inhibitors for the treatment of osteoarthritis. |
| [36] |
Wen ZH, Huang JS, Lin YY, Yao ZK, Lai YC, et al. 2021. Chondroprotective effects of a histone deacetylase inhibitor, panobinostat, on pain behavior and cartilage degradation in anterior cruciate ligament transection-induced experimental osteoarthritic rats. |
| [37] |
Barter MJ, Butcher A, Wang H, Tsompani D, Galler M, et al. 2022. HDAC6 regulates NF-κB signalling to control chondrocyte IL-1-induced MMP and inflammatory gene expression. |
| [38] |
Zheng Y, Chen Y, Lu X, Weng Q, Dai G, et al. 2020. Inhibition of histone deacetylase 6 by tubastatin a attenuates the progress of osteoarthritis via improving mitochondrial function. |
| [39] |
Collins JA, Kapustina M, Bolduc JA, Pike JFW, Diekman BO, et al. 2021. Sirtuin 6 (SIRT6) regulates redox homeostasis and signaling events in human articular chondrocytes. |
| [40] |
Collins JA, Kim CJ, Coleman A, Little A, Perez MM, et al. 2023. Cartilage-specific Sirt6 deficiency represses IGF-1 and enhances osteoarthritis severity in mice. |
| [41] |
Ji ML, Jiang H, Li Z, Geng R, Hu JZ, et al. 2022. Sirt6 attenuates chondrocyte senescence and osteoarthritis progression. |
| [42] |
Ma ZX, Xu H, Xiang W, Qi J, Xu YY, et al. 2021. Deacetylation of FOXO4 by Sirt1 stabilizes chondrocyte extracellular matrix upon activating SOX9. |
| [43] |
Lu Q, Liu P, Miao Z, Luo D, Li S, et al. 2022. SIRT1 restoration enhances chondrocyte autophagy in osteoarthritis through PTEN-mediated EGFR ubiquitination. |
| [44] |
Sacitharan PK, Bou-Gharios G, Edwards JR. 2020. SIRT1 directly activates autophagy in human chondrocytes. |
| [45] |
Zhang Y, Liu Y, Hou M, Xia X, Liu J, et al. 2023. Reprogramming of mitochondrial respiratory chain complex by targeting SIRT3-COX4I2 axis attenuates osteoarthritis progression. |
| [46] |
Mei Z, Yilamu K, Ni W, Shen P, Pan N, et al. 2025. Chondrocyte fatty acid oxidation drives osteoarthritis via SOX9 degradation and epigenetic regulation. |
| [47] |
Shao R, Suo J, Zhang Z, Kong M, Ma Y, et al. 2024. H3K36 methyltransferase NSD1 protects against osteoarthritis through regulating chondrocyte differentiation and cartilage homeostasis. |
| [48] |
Shao R, Zhang Z, Xu Z, Ouyang H, Wang L, et al. 2021. H3K36 methyltransferase NSD1 regulates chondrocyte differentiation for skeletal development and fracture repair. |
| [49] |
Shpargel KB, Starmer J, Yee D, Pohlers M, Magnuson T. 2014. KDM6 demethylase independent loss of histone H3 lysine 27 trimethylation during early embryonic development. |
| [50] |
Dai J, Yu D, Wang Y, Chen Y, Sun H, et al. 2017. Kdm6b regulates cartilage development and homeostasis through anabolic metabolism. |
| [51] |
Jin Y, Liu Z, Li Z, Li H, Zhu C, et al. 2022. Histone demethylase JMJD3 downregulation protects against aberrant force-induced osteoarthritis through epigenetic control of NR4A1. |
| [52] |
Lian WS, Wu RW, Ko JY, Chen YS, Wang SY, et al. 2022. Histone H3K27 demethylase UTX compromises articular chondrocyte anabolism and aggravates osteoarthritic degeneration. |
| [53] |
Lian WS, Wu RW, Ko JY, Chen YS, Wang SY, et al. 2023. Inhibition of histone lysine demethylase 6A promotes chondrocytic activity and attenuates osteoarthritis development through repressing H3K27me3 enhancement of Wnt10a. |
| [54] |
Du X, Chen Y, Zhang Q, Lin J, Yu Y, et al. 2020. Ezh2 ameliorates osteoarthritis by activating TNFSF13B. |
| [55] |
Assi R, Cherifi C, Cornelis FMF, Zhou Q, Storms L, et al. 2023. Inhibition of KDM7A/B histone demethylases restores H3K79 methylation and protects against osteoarthritis. |
| [56] |
Monteagudo S, Cornelis FMF, Aznar-Lopez C, Yibmantasiri P, Guns LA, et al. 2017. DOT1L safeguards cartilage homeostasis and protects against osteoarthritis. |
| [57] |
De Roover A, Núñez AE, Cornelis FM, Cherifi C, Casas-Fraile L, et al. 2021. Hypoxia induces DOT1L in articular cartilage to protect against osteoarthritis. |
| [58] |
Endisha H, Datta P, Sharma A, Nakamura S, Rossomacha E, et al. 2021. microRNA-34a-5p promotes joint destruction during osteoarthritis. |
| [59] |
Nakamura A, Rampersaud YR, Nakamura S, Sharma A, Zeng F, et al. 2019. microRNA-181a-5p antisense oligonucleotides attenuate osteoarthritis in facet and knee joints. |
| [60] |
Tavallaee G, Lively S, Rockel JS, Ali SA, Im M, et al. 2022. Contribution of microRNA-27b-3p to synovial fibrotic responses in knee osteoarthritis. |
| [61] |
Yin CM, Suen WCW, Lin S, Wu XM, Li G, et al. 2017. Dysregulation of both miR-140-3p and miR-140-5p in synovial fluid correlate with osteoarthritis severity. |
| [62] |
Ji ML, Jiang H, Wu F, Geng R, Ya LK, et al. 2021. Precise targeting of miR-141/200c cluster in chondrocytes attenuates osteoarthritis development. |
| [63] |
Wilson TG, Baghel M, Kaur N, Datta I, Loveless I, et al. 2025. Circulating miR-126-3p is a mechanistic biomarker for knee osteoarthritis. |
| [64] |
Wang Y, Li T, Yang Q, Feng B, Xiang Y, et al. 2021. LncRNA THUMPD3-AS1 enhances the proliferation and inflammatory response of chondrocytes in osteoarthritis. |
| [65] |
van Hoolwerff M, Metselaar PI, Tuerlings M, Suchiman HED, Lakenberg N, et al. 2020. Elucidating epigenetic regulation by identifying functional cis-acting long noncoding RNAs and their targets in osteoarthritic articular cartilage. |
| [66] |
Nanus DE, Wijesinghe SN, Pearson MJ, Hadjicharalambous MR, Rosser A, et al. 2020. Regulation of the inflammatory synovial fibroblast phenotype by metastasis-associated lung adenocarcinoma transcript 1 long noncoding RNA in obese patients with osteoarthritis. |
| [67] |
Wang R, Mehrjou B, Dehghan-Banian D, Wang BYH, Li Q, et al. 2025. Targeting long noncoding RNA H19 in subchondral bone osteocytes and the alleviation of cartilage degradation in osteoarthritis. |
| [68] |
Zaccara S, Ries RJ, Jaffrey SR. 2019. Reading, writing and erasing mRNA methylation. |
| [69] |
Liu Q, Li M, Jiang L, Jiang R, Fu B. 2019. METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte. |
| [70] |
Xiao L, Hu B, Ding B, Zhao Q, Liu C, et al. 2022. N(6)-methyladenosine RNA methyltransferase like 3 inhibits extracellular matrix synthesis of endplate chondrocytes by downregulating sex-determining region Y-Box transcription factor 9 expression under tension. |
| [71] |
Sang W, Xue S, Jiang Y, Lu H, Zhu L, et al. 2021. METTL3 involves the progression of osteoarthritis probably by affecting ECM degradation and regulating the inflammatory response. |
| [72] |
Xiong X, Xiong H, Peng J, Liu Y, Zong Y. 2025. METTL3 regulates the m6a modification of NEK7 to inhibit the formation of osteoarthritis. |
| [73] |
He Y, Wang W, Xu X, Yang B, Yu X, et al. 2022. Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m6A modification. |
| [74] |
An X, Wang R, Lv Z, Wu W, Sun Z, et al. 2024. WTAP-mediated m6A modification of FRZB triggers the inflammatory response via the Wnt signaling pathway in osteoarthritis. |
| [75] |
Chen X, Gong W, Shao X, Shi T, Zhang L, et al. 2022. METTL3-mediated m6A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression. |
| [76] |
Zhou H, Shen X, Yan C, Xiong W, Ma Z, et al. 2022. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate osteoarthritis of the knee in mice model by interacting with METTL3 to reduce m6A of NLRP3 in macrophage. |
| [77] |
Kou R, Li T, Fu C, Jiang D, Wang Y, et al. 2024. Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: a nano-based investigation. |
| [78] |
Ye G, Li J, Yu W, Xie Z, Zheng G, et al. 2023. ALKBH5 facilitates CYP1B1 mRNA degradation via m6A demethylation to alleviate MSC senescence and osteoarthritis progression. |
| [79] |
Tang Y, Liu Y, Zhu X, Chen Y, Jiang X, et al. 2023. ALKBH5-mediated m6A demethylation of HS3ST3B1-IT1 prevents osteoarthritis progression. |
| [80] |
Fedeles BI, Singh V, Delaney JC, Li D, Essigmann JM. 2015. The AlkB family of Fe(II)/α-ketoglutarate-dependent dioxygenases: repairing nucleic acid alkylation damage and beyond. |
| [81] |
Yang S, Zhou X, Jia Z, Zhang M, Yuan M, et al. 2023. Epigenetic regulatory mechanism of ADAMTS12 expression in osteoarthritis. |
| [82] |
Jaenisch R, Bird A. 2003. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. |
| [83] |
Guo Q, Li D, Luo X, Yuan Y, Li T, et al. 2021. The regulatory network and potential role of LINC00973-miRNA-mRNA CeRNA in the progression of non-small-cell lung cancer. |
| [84] |
Tang Y, Hong F, Ding S, Yang J, Zhang M, et al. 2023. METTL3-mediated m6A modification of IGFBP7-OT promotes osteoarthritis progression by regulating the DNMT1/DNMT3a-IGFBP7 axis. |
| [85] |
Parker E, Hofer IMJ, Rice SJ, Earl L, Anjum SA, et al. 2021. Multi-tissue epigenetic and gene expression analysis combined with epigenome modulation identifies RWDD2B as a target of osteoarthritis susceptibility. |
| [86] |
Ali SA, Gandhi R, Potla P, Keshavarzi S, Espin-Garcia O, et al. 2020. Sequencing identifies a distinct signature of circulating microRNAs in early radiographic knee osteoarthritis. |
| [87] |
Struys EA. 2013. 2-Hydroxyglutarate is not a metabolite; D-2-hydroxyglutarate and L-2-hydroxyglutarate are! |
| [88] |
Wallace IJ, Worthington S, Felson DT, Jurmain RD, Wren KT, et al. 2017. Knee osteoarthritis has doubled in prevalence since the mid-20th century. |
| [89] |
Yang JH, Hayano M, Griffin PT, Amorim JA, Bonkowski MS, et al. 2023. Loss of epigenetic information as a cause of mammalian aging. |
| [90] |
Kaya-Okur HS, Janssens DH, Henikoff JG, Ahmad K, Henikoff S. 2020. Efficient low-cost chromatin profiling with CUT&Tag. |
| [91] |
Jiang Z, Qi G, He X, Yu Y, Cao Y, et al. 2024. Ferroptosis in osteocytes as a target for protection against postmenopausal osteoporosis. |
| [92] |
Bittner N, Shi C, Zhao D, Ding J, Southam L, et al. 2024. Primary osteoarthritis chondrocyte map of chromatin conformation reveals novel candidate effector genes. |
| [93] |
Boer CG, Hatzikotoulas K, Southam L, Stefánsdóttir L, Zhang Y, et al. 2021. Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations. |
| [94] |
Lin K, Wei L, Wang R, Li L, Song S, et al. 2025. Disrupted methionine cycle triggers muscle atrophy in cancer cachexia through epigenetic regulation of REDD1. |
| [95] |
Hosea Blewett HJ. 2008. Exploring the mechanisms behind S-adenosylmethionine (SAMe) in the treatment of osteoarthritis. |
| [96] |
Shen S, Liang Y, Zhao Y, Hu Z, Huang Y, et al. 2024. Dietary supplementation of vitamin B1 prevents the pathogenesis of osteoarthritis. |
| [97] |
Lin Z, Jiang T, Zheng W, Zhang J, Li A, et al. 2023. N6-methyladenosine (m6A) methyltransferase WTAP-mediated miR-92b-5p accelerates osteoarthritis progression. |
| [98] |
Kaur D, Kaur J, Kamal SS. 2018. Diacerein, its beneficial impact on chondrocytes and notable new clinical applications. |